Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction

Huang-Lian-Jie-Du Decoction (HLJDD) is a classical Traditional Chinese Medicine (TCM) formula with heat-dissipating and detoxifying effects. It is used to treat inflammation-associated diseases. However, no systematic pharmacokinetic (PK) and pharmacodynamic (PD) data concerning the activity of HLJDD under inflammatory conditions is available to date. In the present study, the concentration-time profiles and the hepatic clearance rates (HCR) of 41 major components in rat plasma in response to the oral administration of a clinical dose of HLJDD were investigated by LC-QqQ-MS using a dynamic multiple reaction monitoring (DMRM) method. Additionally, the levels of 7 cytokines (CKs) in the plasma and the body temperature of rats were analyzed. Furthermore, a PK-PD model was established to describe the time course of the hemodynamic and anti-inflammatory effects of HLJDD. As one of the three major active constituents in HLJDD, iridoids were absorbed and eliminated more easily and quickly than alkaloids and flavonoids. Compared with the normal controls, the flavonoids, alkaloids and iridoids in inflamed rats exhibited consistently changing trends of PK behaviors, such as higher bioavailability, slower elimination, delays in reaching the maximum concentration (Tmax) and longer substantivity. The HCR of iridoids was different from that of alkaloids and flavonoids in inflamed rats. Furthermore, excellent pharmacodynamic effects of HLJDD were observed in inflamed rats. The levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β, IL-10, and macrophage inflammatory protein-2 (MIP-2) and body temperature significantly decreased after the administration of HLJDD. Based on PK-PD modeling with the three-phase synchronous characterization of time-concentration-effect, flavonoids exhibited one mechanism of action in the anti-inflammatory process, while iridoids and alkaloids showed another mechanism of action. Taken together, the results demonstrated that HLJDD may restrain inflammation synergistically via its major constituents (alkaloids, flavonoids and iridoids). A correlation between the exposure concentration of different types of compounds and their anti-inflammatory effects in the body was shown. This study provides a comprehensive understanding of the anti-inflammatory activity of HLJDD.

[1]  Hao Hu,et al.  Metabolic fate analysis of Huang–Lian–Jie–Du Decoction in rat urine and feces by LC–IT-MS combining with LC–FT-ICR-MS: a feasible strategy for the metabolism study of Chinese medical formula , 2016, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  Ning Wang,et al.  Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma. , 2015, Journal of ethnopharmacology.

[3]  Shitang Ma,et al.  In silico target fishing for the potential bioactive components contained in Huanglian Jiedu Tang (HLJDD) and elucidating molecular mechanisms for the treatment of sepsis. , 2015, Chinese journal of natural medicines.

[4]  Y. Lv,et al.  Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional Chinese medicine Huanglian Jiedu decoction. , 2014, Journal of ethnopharmacology.

[5]  Weidong Zhang,et al.  Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang. , 2014, Journal of ethnopharmacology.

[6]  Jian-xun Liu,et al.  Pharmacochemistry and integrated pharmacokinetics of six alkaloids after oral administration of Huang-Lian-Jie-Du-Tang decoction , 2014, Journal of Asian natural products research.

[7]  B. Agoram,et al.  At the bench: the key role of PK–PD modelling in enabling the early discovery of biologic therapies , 2014, British journal of clinical pharmacology.

[8]  Meng-Yun He,et al.  Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[9]  S. Senapati,et al.  Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-β Precursor Protein Processing in Alzheimer's Disease Models , 2014, PloS one.

[10]  B. Bian,et al.  [LC-FT-ICR-MS analysis of the prototypes and metabolites in rat plasma after administration of huang-lian-jie-du decoction]. , 2014, Yao xue xue bao = Acta pharmaceutica Sinica.

[11]  L. Kong,et al.  Neuroprotective effects of Huang-Lian-Jie-Du-Decoction on ischemic stroke rats revealed by (1)H NMR metabolomics approach. , 2014, Journal of pharmaceutical and biomedical analysis.

[12]  B. Bian,et al.  Chemical profiling and quantification of Chinese medicinal formula Huang-Lian-Jie-Du decoction, a systematic quality control strategy using ultra high performance liquid chromatography combined with hybrid quadrupole-orbitrap and triple quadrupole mass spectrometers. , 2013, Journal of chromatography. A.

[13]  Weidong Zhang,et al.  Protective effects of Huang-Lian-Jie-Du-Tang and its component group on collagen-induced arthritis in rats. , 2013, Journal of ethnopharmacology.

[14]  Weidong Zhang,et al.  Protective Effects of Huang-Lian-Jie-Du-Tang against Polymicrobial Sepsis Induced by Cecal Ligation and Puncture in Rats , 2013, Evidence-based complementary and alternative medicine : eCAM.

[15]  Jing Zhao,et al.  Bioinformatics Analysis for the Antirheumatic Effects of Huang-Lian-Jie-Du-Tang from a Network Perspective , 2013, Evidence-based complementary and alternative medicine : eCAM.

[16]  M. Nagarkatti,et al.  Role of cytokines as a double-edged sword in sepsis. , 2013, In vivo.

[17]  Liang-Tzung Lin,et al.  The Anticancer Properties and Apoptosis-inducing Mechanisms of Cinnamaldehyde and the Herbal Prescription Huang-Lian-Jie-Du-Tang (黃連解毒湯 Huáng Lián Jiě Dú Tang) in Human Hepatoma Cells , 2013, Journal of traditional and complementary medicine.

[18]  Yuping Tang,et al.  Novel pharmacokinetic studies of the Chinese formula Huang-Lian-Jie-Du-Tang in MCAO rats. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[19]  Yun Zhang,et al.  Huang-Lian-Jie-Du-Tang Protects Rats from Cardiac Damages Induced by Metabolic Disorder by Improving Inflammation-Mediated Insulin Resistance , 2013, PloS one.

[20]  Yu-Ping Tang,et al.  [Study on PK/PD model for traditional Chinese medicine biopharmaceutics based on principle of "correspondence of prescriptions and syndromes"]. , 2013, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[21]  Runhui Liu,et al.  Metabolomic Study of Collagen-Induced Arthritis in Rats and the Interventional Effects of Huang-Lian-Jie-Du-Tang, a Traditional Chinese Medicine , 2013, Evidence-based complementary and alternative medicine : eCAM.

[22]  Runhui Liu,et al.  Rapid-resolution liquid chromatography TOF-MS for urine metabolomic analysis of collagen-induced arthritis in rats and its applications. , 2013, Journal of ethnopharmacology.

[23]  Bo Chen,et al.  Comparative pharmacokinetics of baicalin in normal and the type 2 diabetic rats after oral administration of the Radix scutellariae extract. , 2012, Fitoterapia.

[24]  N. Hou,et al.  Protection of long-term treatment with huang-lian-jie-du-tang on vascular endothelium in rats with type 2 diabetes mellitus. , 2012, Current therapeutic research, clinical and experimental.

[25]  Kayoko Ohura,et al.  Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine. , 2012, Journal of pharmaceutical sciences.

[26]  Lin Han,et al.  Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation. , 2012, Arthritis and rheumatism.

[27]  Yuping Tang,et al.  Integrated pharmacokinetics of major bioactive components in MCAO rats after oral administration of Huang-Lian-Jie-Du-Tang. , 2012, Journal of ethnopharmacology.

[28]  Ying-Ju Lai,et al.  In vivo and in vitro inhibitory effects of a traditional Chinese formulation on LPS-stimulated leukocyte-endothelial cell adhesion and VCAM-1 gene expression. , 2012, Journal of ethnopharmacology.

[29]  Weidong Zhang,et al.  The inhibitory activities of the components of Huang-Lian-Jie-Du-Tang (HLJDT) on eicosanoid generation via lipoxygenase pathway. , 2011, Journal of ethnopharmacology.

[30]  L. Kong,et al.  Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. , 2011, Journal of ethnopharmacology.

[31]  Haoru Zhao,et al.  [Research progress on current pharmacokinetic evaluation of Chinese herbal medicines]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[32]  Li-wei Guo,et al.  Comparative pharmacokinetics of baicalin in plasma after oral administration of Huang-Lian-Jie-Du-Tang or pure baicalin in MCAO and sham-operated rats. , 2010, Fitoterapia.

[33]  Xiao-dong Liu,et al.  Increased oral AUC of baicalin in streptozotocin-induced diabetic rats due to the increased activity of intestinal beta-glucuronidase. , 2010, Planta Medica.

[34]  Xiao-Hua Liu,et al.  Huang‐Lian‐Jie‐Du‐Tang exerts anti‐inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway , 2009, The Journal of pharmacy and pharmacology.

[35]  Dae-Duk Kim,et al.  Contribution of a significant first‐pass effect of dimethyl‐4,4′‐dimethoxy‐5,6,5′,6′‐dimethylene dioxybiphenyl‐2,2′‐dicarboxylate in the liver to its poor bioavailability in rats , 2009 .

[36]  S. Sohn,et al.  Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[37]  Dipendra K. Aryal,et al.  Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect. , 2009, Journal of pharmaceutical sciences.

[38]  Runhui Liu,et al.  LC–DAD and LC–ESI–MS Chromatographic Fingerprinting and Quantitative Analysis for Evaluation of the Quality of Huang-Lian-Jie-Du-Tang , 2009 .

[39]  Weidong Zhang,et al.  Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway. , 2009, The Journal of pharmacy and pharmacology.

[40]  Y. Zhang,et al.  Simultaneous determination of 24 sulfonamide residues in meat by ultra-performance liquid chromatography tandem mass spectrometry. , 2008, Journal of chromatography. A.

[41]  J. V. Sarma,et al.  Adverse functions of IL‐17A in experimental sepsis , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Q. Liao,et al.  Simultaneous determination of berberine, palmatine and jatrorrhizine by liquid chromatography-tandem mass spectrometry in rat plasma and its application in a pharmacokinetic study after oral administration of coptis-evodia herb couple. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[43]  F. Lu,et al.  [Effects of Huanglian Jiedu Decoction on phosphatidylinositol-3-kinase expression in target tissues of type 2 diabetic rats]. , 2007, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[44]  Guangji Wang,et al.  Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix scutellariae extract and Huang-Lian-Jie-Du-Tang to rats. , 2007, Journal of ethnopharmacology.

[45]  P. Wludyka,et al.  Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. , 2007, Journal of pediatric surgery.

[46]  A. Ishige,et al.  An herbal medicine orengedokuto prevents indomethacin-induced enteropathy. , 2007, Biological & pharmaceutical bulletin.

[47]  M. Morita,et al.  Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco‐2 cells through multidrug resistance‐associated protein 2 , 2007, The Journal of pharmacy and pharmacology.

[48]  Xiao-dong Liu,et al.  High-performance liquid chromatographic method for the determination and pharmacokinetic study of wogonoside in rat serum after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction. , 2006, Biomedical chromatography : BMC.

[49]  Chenggang Huang,et al.  Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography. , 2006, Biomedical chromatography : BMC.

[50]  Ji-sheng Ma,et al.  [Study on antitumor activities of huanglian jiedu decoction]. , 2006, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[51]  Ji-sheng Ma,et al.  [Comparison between antitumor effect and chemical constituents of Huanglian Jiedu decoction and that of serum containing Huanglian Jiedu decoction]. , 2006, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[52]  정혜진,et al.  Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats , 2006 .

[53]  J. Xing,et al.  Absorption and enterohepatic circulation of baicalin in rats. , 2005, Life sciences.

[54]  F. Lu,et al.  [Protective effects of Huanglian Jiedu decoction on vascular endothelial function in type 2 diabetic rats]. , 2005, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[55]  Z. Zuo,et al.  Role of Intestinal First-Pass Metabolism of Baicalein in its Absorption Process , 2005, Pharmaceutical Research.

[56]  N. Tsuyama,et al.  Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. , 2005, Blood.

[57]  Michael E. Swartz,et al.  UPLC™: An Introduction and Review , 2005 .

[58]  Michael E. Swartz,et al.  UPLC TM : An Introduction and Review , 2005 .

[59]  A. Shum,et al.  The effects of the cyclosporin A, a P‐glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study , 2002, British journal of pharmacology.

[60]  K. Kobashi,et al.  Balicalin, the Predominant Flavone Glucuronide of Scutellariae Radix, is Absorbed from the Rat Gastrointestinal Tract as the Aglycone and Restored to its Original Form , 2000, The Journal of pharmacy and pharmacology.

[61]  T. Fukuoka,et al.  Suppression of neuropeptides' mRNA expression by herbal medicines in a rat model of peripheral inflammation. , 1999, Life sciences.

[62]  Y. Suzuki,et al.  A novel method for measuring the hepatic first-pass effect and metabolic rate of L-3,4-dihydroxyphenylalanine (DOPA), diazepam and inulin in rat liver. , 1998, Biological and Pharmaceutical Bulletin.

[63]  Jonghan Kim,et al.  Liver and Gastrointestinal First‐pass Effects of Azosemide in Rats , 1997, The Journal of pharmacy and pharmacology.

[64]  Y. Koike,et al.  Effects of Oren‐gedoku‐to and Unsei‐in, Chinese Traditional Medicines, on Interleukin‐8 and Superoxide Dismutase in Rats , 1997, The Journal of pharmacy and pharmacology.

[65]  F. Lu,et al.  Protective and therapeutic effects of huanglian-jie-du-tang on hepatotoxin-induced liver injuries. , 1996, The American Journal of Chinese Medicine.